As 2024 winds down, Dr. Anne Marie Morse provides a run-down of the most important trends, and therapeutic innovations to occur in sleep medicine this year, and what to look forward to in the sleep space in 2025.
Advertisement
Lauren Averett Byers, MD, will be honored with the award during the TAMEST Annual Conference in February.
A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies.
The foundation's 2024 Scientific Grant Program awards mark the "largest single-year investment in its history.”
A study examined the impact of hemodiafiltration versus hemodialysis in patients with end-stage renal disease.
Home-based exercise programs after lung cancer resection do not improve physical function in patients with NSCLC.
CERTAIN registry data were used to assess age-related differences in outcomes among pediatric kidney transplant recipients.
SBRT with sorafenib is shown to be associated with a clinically important but not statistically significant improved OS rate.
Study Highlights Importance of Pretreatment Frailty Assessments for Older Adults With Advanced NSCLC
Implementing pretreatment frailty assessments into clinical workflows may help identify patients at risk of poor outcomes.Advertisement
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
SBRT with sorafenib is shown to be associated with a clinically important but not statistically significant improved OS rate.
Data on growing pancreatic cancer cases in young Americans shows that some cases are misattributed as early endocrine cancer.
A recent study utilized patient data from 13 medical centers in a biomarker analysis of 1L ICIs with & without ...
A recent observational study determined if there is a correlation between the improvement of ADR and lower rates of CRC.
The designation is based on positive results from an ongoing collaborative trial between GSK and MSK Cancer Center.
Dr. Joseph Cullen discusses the combination of vitamin C with gemcitabine and nab-paclitaxel for pancreatic cancer.
The Latest From Heme Today
This approval for patients aged 12 years and older was based on findings from the explorer7 phase III clinical trial.
An MDS HSPC signature generated from the model presents possible targets for treatment in patients with low-risk disease.
The study's results especially highlight potential aberrant gene regulation by ZMAT2 and SMARCD3.
The study showed a mortality risk reduction benefit in certain mutations while for others larger studies are needed.
Researchers noted that confirmation of this relationship in lower-risk disease would require a larger study.
The approval was based on the findings from the phase III MSB-GVHD001 clinical study.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.